Related by context. All words. (Click for frequent words.) 70 SNT MC# 69 IMiDs 69 P#X# antagonist 69 bardoxolone 69 acetonide FA 68 Archexin 68 Panzem 68 Evoltra ® 68 HCV protease inhibitors 68 metaglidasen 67 Phenoptin 67 volociximab 67 relapsing remitting MS RRMS 67 dirucotide MBP# 67 oral prodrug 67 JAK inhibitor 67 Anavex #-# 67 Prestara 67 Panzem R 67 Diamyd ® 67 methylnaltrexone 67 HeFH 67 Zavesca r 67 HQK 67 drug ISA# 67 Aviptadil 67 Aflibercept 67 Octreolin 66 Maxy G# 66 LymphoStat B TM 66 Cethrin 66 aerosolized AAT 66 Personalized Immunotherapy 66 receptor tyrosine kinase inhibitor 66 ulimorelin 66 Insegia 66 mertansine 66 PDE# inhibitors 66 aldehyde dehydrogenase ALDH2 deficiency 66 HCD# [002] 66 lumiliximab 66 Fx #A 66 opioid bowel dysfunction 66 TELINTRA 66 dexanabinol 66 HepeX B 66 refractory gout 66 CYT# potent vascular disrupting 66 immunosuppressant therapies 66 Canvaxin TM 66 MAGE A3 ASCI 66 targeted radiotherapeutic 66 GED aPC 66 MAXY VII 66 torezolid phosphate 66 Fodosine 66 kidney urologic 66 lintuzumab SGN 66 Aplidin 66 OHR/AVR# 66 ularitide 65 squalamine 65 Actimmune ® 65 Shigamabs ® 65 inflammatory autoimmune diseases 65 severe gastroparesis 65 post herpetic neuralgia PHN 65 EVIZON TM squalamine lactate 65 idiopathic thrombocytopenic purpura ITP 65 MAXY alpha 65 diabetic gastroparesis 65 rheumatoid arthritis psoriatic arthritis 65 ATL# [002] 65 Troxatyl 65 neovascular diseases 65 Aryplase 65 induced macular edema 65 HuMax TAC 65 Virulizin ® 65 Sebivo 65 TBC# 65 Dacogen injection 65 atacicept 65 glucokinase activator 65 systemic fungal infections 65 relapsed multiple myeloma 65 HuLuc# 65 Cetrorelix 65 Campath ® 65 YONDELIS 65 MAXY G# 65 FOLOTYN ® 65 secondary hyperparathyroidism 65 Catena ® 65 OvaRex ® MAb 65 SNT-MC#/idebenone 65 HuMax CD4 65 forodesine 65 retinal vein occlusion induced 65 Granulocyte Colony Stimulating Factor 65 visilizumab 65 TRAIL receptor antibodies 65 R#/MEM # 65 diabetic kidney 65 sJIA 65 BrachySil TM 65 Factor VIIa 65 teplizumab 65 TH# [003] 65 Cx# [002] 65 CCR5 mAb 65 opioid induced bowel dysfunction 65 amrubicin 65 UPLYSO 65 Zavesca ® 65 Firazyr 65 MKC# MT 65 Iluvien ® 65 BiovaxID TM 65 R sorafenib tablets 65 Meets Primary Endpoint 65 RhuDex ® 65 Zenapax 65 novel oral anticoagulant 65 Evoltra 65 omecamtiv mecarbil 65 investigational monoclonal antibody 65 constipation predominant irritable bowel 65 Kepivance 64 steroid refractory GvHD 64 PRT# 64 methylnaltrexone bromide 64 Symadex 64 Tasimelteon 64 alvespimycin 64 vidofludimus 64 Spiegelmer ® 64 Safinamide 64 Initiates Clinical 64 AEG# 64 Xcytrin R 64 MEK inhibitor 64 IMiDs ® 64 E1 INT TM 64 multiple myeloma MM 64 solanezumab 64 midstage trials 64 Apaziquone 64 riociguat 64 novel therapeutic antibodies 64 cannabinor 64 GRN# 64 Phase IIb clinical trials 64 Initiates Enrollment 64 thetreatment 64 AERx iDMS 64 Icatibant 64 ADP receptor antagonist 64 class mGluR5 inhibitor 64 Genentech Rituxan 64 talactoferrin 64 mGluR2 NAM 64 PI3K/Akt pathway inhibitor 64 Clolar ® 64 Entereg R 64 Somatuline Depot 64 GVAX ® 64 JAK inhibitors 64 ocrelizumab 64 ocular inflammatory 64 EVIZON TM 64 small molecule thrombopoietin 64 proteasome inhibitor 64 ABILIFY ® 64 Begins Dosing 64 PD LID 64 tramiprosate Alzhemed TM 64 OMNARIS HFA 64 myeloproliferative diseases 64 Golimumab 64 GALNS 64 PNP inhibitor 64 TRIOLEX HE# APOPTONE HE# 64 reslizumab 64 DPP4 inhibitor 64 Friedreich Ataxia FRDA 64 Initiates Phase II 64 HuMax EGFr 64 recombinant biopharmaceutical 64 PDE4 inhibitor 64 Pegloticase 64 KSP inhibitor 64 phase IIb trial 64 synthetic retinoid 64 ILUVIEN ® 64 EP #R 64 Panzem R NCD 64 RELOVAIR ™ 64 Microplasmin 64 IV APAP 64 Tamibarotene 64 familial hypercholesterolemia FH 64 ThermoDox R 64 catheter occlusion 64 eritoran 64 hyperphenylalaninemia HPA due 64 Proquin XR 64 Ceflatonin 64 post operative ileus 64 Dosa suffers 64 orally administered inhibitor 64 Benlysta belimumab 64 Azilect ® 64 calcineurin inhibitor 64 Solazed 64 pediatric Crohn disease 64 RELISTOR ® 64 Amrubicin 64 gastrointestinal mucositis 64 Potelligent Technology 64 Zenvia ™ 64 RAPTIVA 64 IV Busulfex 64 diarrhea predominant irritable 64 generation purine nucleoside 64 immunomodulatory therapy 64 Civacir 64 incyclinide 64 luliconazole 64 Onconase 64 XL# anticancer compounds 64 ARIKACE ™ 64 Myocet 64 schizophrenia CIAS 64 Solazed TM 64 selective androgen receptor modulator 63 sorafenib tablets 63 neurogenic orthostatic hypotension 63 rasagiline tablets 63 TransVax ™ 63 Soliris TM eculizumab 63 oxypurinol 63 novel VDA molecule 63 IAP inhibitor 63 Optiquel ™ 63 MyVax ® 63 SPRYCEL ® 63 relapsed leukemia 63 Budesonide foam crofelemer 63 Plicera 63 lomitapide 63 Alzhemed TM 63 liposomal formulation 63 Diabetic Macular Edema 63 otelixizumab 63 invasive candidiasis 63 maribavir 63 ALN VSP Phase 63 Gleevec imatinib mesylate 63 phase III isavuconazole 63 rufinamide 63 Collategene 63 oxymorphone ER 63 systemically administered 63 CCR9 antagonist 63 CDP# 63 urocortin 2 63 Sudhir Agrawal D.Phil 63 davunetide intranasal AL 63 CTAP# Capsules 63 TACI Ig 63 Ecallantide 63 delivers fluocinolone acetonide FA 63 Nanobody R 63 AQ4N 63 oral nucleoside analogue 63 Akt inhibitor 63 beta 1a 63 Viramidine 63 LymphoStat B belimumab 63 Ceflatonin R 63 cutaneous T 63 valtorcitabine 63 Bezielle 63 NP2 Enkephalin 63 XIAFLEX ® 63 budesonide foam 63 Enbrel Humira 63 pradefovir 63 IAP inhibitors 63 IL# PE#QQR 63 noninfectious uveitis 63 Ophena TM 63 pouchitis 63 anti inflammatory NSAID 63 refractory APL 63 HIV integrase inhibitors 63 perampanel 63 midstage clinical 63 Nuvion 63 SinuNase TM 63 LPLD 63 Annamycin 63 terlipressin 63 EVIZON ™ 63 tramiprosate ALZHEMED TM 63 esophageal candidiasis 63 Maribavir 63 faropenem 63 Mipomersen 63 hoFH 63 Cimzia TM 63 MyVax R 63 Arranon 63 psoriasis rheumatoid arthritis 63 CINOD 63 herpes zoster shingles 63 Cancidas 63 elotuzumab 63 Daclizumab 63 pharmacological chaperone 63 PresbyLens ® 63 Fibrillex TM 63 Glypromate 63 diabetic macular edema DME 63 IMiDs R 63 PEG SN# 63 PrevOnco ™ 63 BRAF V# mutation 63 dirucotide 63 BCR ABL inhibitors 63 RANK Ligand inhibitor 63 INCB# [001] 63 JAK2 inhibitor 63 Allovectin 7 63 DU #b 63 cancer neuroendocrine tumor 63 ophthalmic diseases 63 Panzem ® 63 AZILECT ® 63 Amgen Neulasta ® 63 Aganocide 63 Nicole Onetto MD 63 intranasal formulation 63 MKC# 63 BENLYSTA ® 63 IRX 2 63 Fast Track designations 63 Allovectin 7 ® 63 TYZEKA 63 Gleevec Glivec 63 Urocidin TM 63 dimebon latrepirdine 63 Zemiva TM 63 relapsed MM 63 MNTX 63 Deferiprone 63 panitumumab Vectibix 63 Prodarsan R 62 toenail onychomycosis 62 thalidomide Thalomid 62 SJIA 62 Arcalyst 62 albiglutide 62 Canvaxin 62 ospemifene 62 Proleukin 62 Lupuzor 62 regorafenib 62 either acutely decompensated 62 Aurexis 62 candidate TNFerade biologic 62 CDAD Clostridium difficile 62 BRAF inhibitor 62 PHX# 62 SUTENT ® 62 Cleviprex TM clevidipine 62 Muraglitazar 62 ZADAXIN ® 62 zanolimumab 62 herpetic keratitis 62 non alcoholic steatohepatitis 62 cMET 62 AzaSite Plus 62 Crofelemer budesonide foam 62 Xanafide 62 SinuNase 62 novel synthetic PEGylated 62 GERD migraine headaches 62 Allovectin 7 R 62 mitoxantrone plus 62 Traficet EN 62 tezampanel NGX# 62 retinal vein occlusion 62 epothilone 62 ruxolitinib 62 Dapagliflozin 62 TREANDA 62 relapsed ALL 62 mGluR5 NAM 62 Amgen Neulasta R 62 formerly LymphoStat B 62 Ketotransdel 62 Soliris eculizumab 62 diabetic retinopathy DR 62 SILENOR 62 phase IIb clinical 62 Orphan Drug designations 62 Neulasta R 62 Submits Response 62 postoperative ileus 62 FRDA 62 LEUKINE 62 Peginterferon alfa 2b 62 AzaSite TM 62 Fabry Disease 62 constipation OIC 62 Azedra 62 Ribavirin causes 62 Phase #b/#a 62 heterozygous FH 62 pathologic myopia 62 SAR# [002] 62 Tß4 62 TRO# 62 Completes Patient Enrollment 62 RH1 62 Aganocide ® 62 Presents Preclinical 62 CINTREDEKIN BESUDOTOX 62 interferon gamma 1b 62 nephropathic cystinosis 62 commercialize deforolimus 62 lixivaptan 62 Silodosin 62 compound INCB# 62 SomatoKine 62 Epratuzumab 62 chronic ITP patients 62 sitaxsentan 62 eprotirome 62 adenosine A2A 62 ICA # 62 Hsp# inhibition 62 Orphan Status 62 XL# XL# 62 NV1FGF 62 metastatic carcinoid 62 Initiate Clinical Trial 62 MDS AML 62 Cinryze ™ 62 successfully commercialize Iluvien 62 molecular chaperone regulation 62 R roscovitine 62 candidate Zenvia 62 ZOLINZA 62 Tyzeka Sebivo 62 Pivotal Phase 62 vascular disrupting agents 62 TTR amyloidosis 62 tafamidis 62 ® natalizumab 62 investigational humanized monoclonal antibody 62 autoimmune uveitis 62 gastro intestinal inflammation 62 voclosporin 62 vascular disrupting agent 62 Sutent sunitinib 62 dasatinib Sprycel ® 62 Cloretazine 62 ASONEP 62 CytoFab ™ 62 Squalamine 62 Prochymal TM 62 biologic therapeutics 62 IMA# 62 rheumatoid arthritis gout 62 cognitive impairment associated 62 intranasal insulin product 62 G#DT 62 Pafuramidine 62 recombinant factor VIIa 62 Lu AA# 62 RhuDex R 62 topical NSAID 62 oral methylnaltrexone 62 Amigal 62 Hepatitis C HCV 62 Phase 2b Clinical Trial 62 molecular imaging radiopharmaceutical 62 vaginally administered lidocaine 62 refractory acute myeloid 62 AKT inhibitor 62 pediatric acute lymphoblastic 62 hypoxia activated prodrug 62 ProSavin 62 refractory angina 62 vemurafenib 62 Difimicin 62 sargramostim 62 rALLy 62 CCR5 antagonist 62 Clevudine 62 indolent NHL 62 Lupus nephritis 62 RTP #i 62 Asentar 62 BZL# 62 Intravenous CP 62 Tolvaptan 62 opioid induced constipation OIC 62 Pimavanserin 62 Vitrasert R 62 Thalomid ® 62 nucleoside analog 62 blood clot dissolver 62 Lixivaptan 62 ALN PCS 62 ophthalmic indications 62 coagulation disorders 62 deforolimus 62 oral picoplatin 62 non nucleoside inhibitor 62 REGN# 62 systemic juvenile idiopathic 62 pain palliation 62 severe hypersensitivity reactions 62 candidate deforolimus 62 Octreotide 62 oral dnaJP1 62 CORLUX CORT # 62 Genasense ® 62 INSPIRE Trial Phase III 62 MOVIPREP R 62 elacytarabine 62 skeletal sarcomere activator 62 VGV 1 62 Cinquil 62 CD# CEA 62 Zavesca R 62 cathepsin K inhibitor 62 RezularTM 62 OvaRex R 62 neuro inflammatory 62 mitogen activated ERK kinase 62 rilonacept 62 CytoFab 62 NEUMUNE 62 KIACTA ™ 62 Cardio Vascu Grow 62 Diamyd R 62 investigational compounds 62 DEB# 62 telaprevir VX 62 Tramiprosate ALZHEMED TM 62 Tarceva TM 62 Pruvel 62 eosinophilic asthma 62 Nexavar sorafenib 62 adult chronic ITP 61 Virulizin 61 benign prostatic hypertrophy BPH 61 unoprostone isopropyl 61 Glatiramer Acetate 61 intranasal delivery 61 fusion enhancers 61 Mepact 61 Simulect 61 cinacalcet HCl 61 Gemzar gemcitabine 61 MKC# MKC# PP 61 Phase III Pivotal 61 diabetic nephropathy 61 Onalta ™ 61 neuropathic pain spasticity 61 CRF1 receptor antagonist 61 p# MAP kinase inhibitor 61 KNS # 61 Camvia 61 Omacetaxine 61 INS# [001] 61 baminercept 61 prostone 61 develop HBV reactivation 61 Actemra tocilizumab 61 Aloxi R 61 SYCREST 61 Proxinium TM 61 DPX Survivac 61 Initiates Phase III 61 motesanib 61 Receives Orphan Drug 61 fibrotic disease 61 forodesine hydrochloride 61 Nalmefene 61 omega interferon 61 LEP ETU 61 Phase #b/#a trial 61 mTOR inhibitor 61 MET inhibitor 61 KAPVAY ™ 61 ecallantide 61 hypereosinophilic syndrome 61 dexpramipexole 61 oncolytic virus therapies 61 chronic HCV infection 61 selective modulator 61 ATG Fresenius S 61 Methylnaltrexone 61 Tavocept 61 Leukine ® 61 Granted Orphan Drug 61 Prodarsan ® 61 Onalta 61 OncoVex 61 Anti VEGF 61 PSMA ADC 61 UVIDEM 61 EndoTAG TM -1 61 pomalidomide 61 recurrent glioblastoma 61 Cellegesic 61 Onco TCS 61 TKM ApoB 61 leukemia AML 61 R lenalidomide 61 acadesine 61 GW# [003] 61 sulfonylurea glimepiride 61 humanized interleukin 6 61 Romiplostim 61 CEQ# 61 osteoarthritis rheumatoid arthritis 61 evaluating picoplatin 61 THR beta agonist 61 Major Depressive Disorder MDD 61 glucagon receptor 61 inhaled AAT 61 Urocidin 61 tezampanel 61 IMiDs ® compound 61 Acute Radiation Syndrome ARS 61 sodium glucose transporter 61 prokinetic agent 61 including eniluracil ADH 61 TNF alpha inhibitor 61 nucleotide analog 61 Pyridorin 61 Hematide ™ peginesatide 61 lupus multiple sclerosis 61 Laquinimod 61 tamibarotene 61 PEGylated interferon beta 1a 61 ostarine 61 Cimzia ® certolizumab pegol 61 unresectable stage 61 obatoclax 61 rolapitant 61 HGS# 61 tetrabenazine 61 Certolizumab pegol 61 histone deacetylase HDAC inhibitor 61 EGS# 61 Cushing Syndrome 61 etanercept Enbrel 61 plasma kallikrein inhibitor 61 nalbuphine ER 61 Somatuline R Depot 61 isavuconazole 61 factor VIIa 61 Cethrin R 61 candidate CRLX# 61 chemotherapy induced neutropenia 61 Pivotal Phase III 61 canagliflozin 61 huC# DM4 61 Investigational Treatment 61 orphan designation 61 ZFP Therapeutics 61 FDA Orphan Drug 61 bardoxolone methyl 61 Zybrestat 61 topical ophthalmic 61 metastatic malignant 61 antiarrhythmic 61 Chrysalin 61 ONCONASE R 61 BioNumerik 61 hematological malignancy 61 pamidronate 61 PEG PAL 61 Talabostat 61 Kuvan R 61 initiate Phase 1b 61 CIMZIA TM 61 topical anti infective 61 XP# XP# 61 eniluracil 61 E2F Decoy 61 SinuNase ™ 61 PEGylated interferon 61 Zerenex 61 Orphan Drug status 61 sulodexide 61 metastatic sarcomas 61 clobazam 61 Hepatitis C Virus HCV 61 venous stasis ulcers 61 anti fibrotic 61 advanced carcinoid 61 ENMD # 61 Exelixis compounds 61 refractory chronic lymphocytic 61 Albugon 61 Pirfenidone 61 neurology immunology 61 Alvesco R 61 Aceon 61 diabetic macular edema 61 Loramyc ™ 61 Zenyaku Kogyo 61 2A receptor agonist 61 MT#/MEDI-# 61 reduce serum phosphate 61 null responder 61 Leber Congenital Amaurosis LCA 61 SGS# 61 AMEVIVE 61 immune thrombocytopenic purpura ITP 61 Triapine R 61 TG# [003] 61 Trofex 61 patientswith 61 Raptiva R 61 faropenem medoxomil 61 polycythemia vera essential thrombocythemia 61 Campath alemtuzumab 61 MEK inhibitors 61 demonstrated antitumor activity 61 novel emulsion formulation 61 Achieves Primary Endpoint 61 Raptiva ® 61 ACZ# 61 orphan medicinal product 61 Zadaxin 61 PRTX 61 Hervé Hoppenot President 61 gefitinib Iressa 61 Tyrima 61 Sapacitabine 61 MYDICAR ® 61 Bayer Onyx 61 oral anti arrhythmic 61 anticancer therapy 61 TEMODAL 61 DCVax R 61 essential thrombocythemia ET 61 oral RSD# 61 tubulin inhibitor 61 Genz # 61 ALTROPANE R 61 TLR8 agonist 61 sterile lidocaine patch 61 ZFP Therapeutic 61 Indaflex TM 61 Cryopyrin Associated Periodic Syndromes 61 choroidal vasculopathy 61 delta gamma agonist 61 Syncria 61 Lumacan 61 PEGylated Fab fragment 61 Marqibo TM 61 Rasagiline 61 Stargardt Macular Dystrophy SMD 61 Vicriviroc 61 Velcade bortezomib 61 Fludara ® 61 Desmoteplase 61 Gleevec imatinib 61 oral FTY# 61 Arimoclomol 61 anticancer compound 61 therapeutic monoclonal antibody 61 L BLP# 61 anterior uveitis 61 R bendamustine hydrochloride 61 aflibercept VEGF Trap 61 endothelin antagonist 61 prescribed proton pump 61 gastrointestinal stromal tumors GIST 61 atypical hemolytic uremic syndrome 61 Initiates Clinical Trial 61 Severe Primary IGFD 61 Gleevec resistant 61 relapsing MS 61 novel histone deacetylase 61 MAA submission 61 epinastine nasal spray 61 Receives Orphan Drug Designation 61 small molecule glucokinase 61 tremelimumab 61 SPRIX ® 61 LHRH antagonists 61 GLPG# 61 relapsed refractory multiple myeloma 61 hepatitis C HCV 61 refractory CLL 61 rhIGF-I/rhIGFBP-3 61 chronic myocardial ischemia 61 Oglemilast 61 recurrent glioblastoma multiforme 61 LHON 61 ganetespib 61 Macular edema 61 BAY #-# 61 Kissei Pharmaceutical 61 tuberous sclerosis TS 61 oral salmon calcitonin 61 FROVA 61 Enzyme Replacement Therapy 61 corticosteroid dexamethasone 61 sapropterin dihydrochloride Tablets 61 Hsp# Inhibitor 61 pulmonary arterial hypertension PAH 61 JAK3 inhibitor 61 Apoptone 61 Certolizumab 61 TOCOSOL 61 erlotinib Tarceva ® 61 AzaSite Xtra 61 Vimpat R 61 Intravitreal injections 61 Rescula 61 immuno modulatory 61 ganaxolone 61 posterior uveitis 61 markets Testim ® 60 rThrombin 60 oral ghrelin agonist 60 Gamunex C 60 PROCRIT ® 60 EOquin TM 60 treatment naïve genotype 60 Vectical 60 phase IIa clinical 60 Frova ® 60 HGS ETR1 mapatumumab 60 Exherin 60 acyclovir Lauriad R 60 Parkinson disease levodopa induced 60 ELACYT 60 TYSABRI natalizumab 60 CMV vaccine 60 immunotherapeutic approaches 60 AAG geldanamycin analog 60 Phase IIa trials 60 Dacetuzumab 60 MediGene focuses 60 Pazopanib 60 chorea associated 60 FORADIL 60 Vilazodone 60 GRNCM1 60 cilengitide 60 tiapamil 60 Surfaxin LS 60 Announces Poster Presentations 60 selective S#P# receptor agonist 60 Anidulafungin 60 Severe VOD 60 Cloretazine ® 60 Levetiracetam 60 inhaled antibiotic 60 ozarelix 60 Initiate Phase 60 Allos retains exclusive 60 non nucleoside HCV 60 CG# [003] 60 compound ISA# 60 AA amyloidosis 60 de novo kidney transplant 60 Remicade infliximab 60 CRMD# 60 rALLy clinical trial 60 Successfully Completes Phase 60 VEGF Trap 60 isoform selective 60 chronic thromboembolic pulmonary 60 Manja Bouman CEO 60 Retinitis Pigmentosa RP 60 ponatinib 60 DDP# 60 PSN# [001] 60 Zirgan 60 Cerimon 60 Hedgehog antagonist 60 seliciclib CYC# 60 Interferon beta 60 Combivir Kivexa 60 Guanilib 60 teduglutide 60 prematurity Stargardt disease 60 hypocalcaemia 60 Exherin TM 60 Q#IR 60 Degarelix 60 PGL# 60 TNF Tumor Necrosis Factor 60 ZYBRESTAT 60 dacetuzumab 60 Amphotericin B 60 Unit Dose Budesonide 60 BEMA TM Fentanyl 60 Phase Ib IIa 60 Prodarsan 60 Atiprimod 60 vaginal candidiasis 60 PEGylated anti 60 OMP #R# 60 peptidic compound 60 Oncaspar 60 MELAS 60 ATryn ® 60 lenalidomide dexamethasone 60 Hepatocellular Carcinoma HCC 60 PSN# [002] 60 Phase 2a Trial 60 PrevOnco 60 subsidiaries visit http:/www.apricusbio.com 60 Diamyd r 60 IPL# 60 nitric oxide donating prostaglandin 60 canakinumab 60 Viprinex 60 icatibant 60 miconazole Lauriad ® 60 Forodesine HCl 60 RNAi therapeutic targeting PCSK9 60 Androxal TM 60 TM pralatrexate injection 60 AMPK activators 60 TLK# 60 rheumatoid arthritis Crohn disease 60 LibiGel ® 60 sodium stibogluconate 60 markets HP Acthar 60 dopaminergic therapy 60 Amigal TM 60 chemopreventive agent 60 rheumatoid arthritis thrombocytopenia 60 Evoltra TM 60 INTEGRILIN 60 octreotide implant 60 ATL# [001] 60 INTEGRILIN R eptifibatide Injection 60 ONTAK 60 Vectibix panitumumab 60 vosaroxin 60 homozygous familial hypercholesterolemia 60 HCV RNA polymerase 60 anti angiogenic agents 60 Noxafil 60 NU# direct 60 Phase IIIb clinical 60 VEGF inhibitors 60 Vidaza R 60 humanized therapeutic 60 PPAR gamma agonist 60 anticancer therapeutics 60 selective GR 60 ATL/TV# 60 OXi# 60 EGFR inhibitors 60 Vicinium TM 60 AZILECT R 60 NTDDS 60 Bendamustine 60 immunological diseases 60 RNAi therapeutic targeting 60 gepirone ER 60 nicotinic alpha 7 60 multi kinase inhibitor 60 alpha interferons 60 BCR ABL inhibitor 60 ORENCIA R 60 lucinactant 60 cytokine refractory 60 Temodar ® 60 unresectable HCC 60 oral ridaforolimus 60 decompensated liver disease 60 Vertex retains 60 vaso occlusive crisis 60 Protexia R 60 subcutaneous formulation 60 idiopathic pulmonary fibrosis IPF 60 Immunotherapeutic 60 ACAPODENE TM 60 Kit CD# positive